486 related articles for article (PubMed ID: 12018775)
1. Alterations of amino acids and monoamine metabolism in male Fmr1 knockout mice: a putative animal model of the human fragile X mental retardation syndrome.
Gruss M; Braun K
Neural Plast; 2001; 8(4):285-98. PubMed ID: 12018775
[TBL] [Abstract][Full Text] [Related]
2. Age- and region-specific imbalances of basal amino acids and monoamine metabolism in limbic regions of female Fmr1 knock-out mice.
Gruss M; Braun K
Neurochem Int; 2004 Jul; 45(1):81-8. PubMed ID: 15082225
[TBL] [Abstract][Full Text] [Related]
3. Increased rates of cerebral glucose metabolism in a mouse model of fragile X mental retardation.
Qin M; Kang J; Smith CB
Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15758-63. PubMed ID: 12427968
[TBL] [Abstract][Full Text] [Related]
4. Fragile X-like behaviors and abnormal cortical dendritic spines in cytoplasmic FMR1-interacting protein 2-mutant mice.
Han K; Chen H; Gennarino VA; Richman R; Lu HC; Zoghbi HY
Hum Mol Genet; 2015 Apr; 24(7):1813-23. PubMed ID: 25432536
[TBL] [Abstract][Full Text] [Related]
5. Reduced cortical synaptic plasticity and GluR1 expression associated with fragile X mental retardation protein deficiency.
Li J; Pelletier MR; Perez Velazquez JL; Carlen PL
Mol Cell Neurosci; 2002 Feb; 19(2):138-51. PubMed ID: 11860268
[TBL] [Abstract][Full Text] [Related]
6. Fmr1 knockout mice: a model to study fragile X mental retardation. The Dutch-Belgian Fragile X Consortium.
Cell; 1994 Jul; 78(1):23-33. PubMed ID: 8033209
[TBL] [Abstract][Full Text] [Related]
7. Altered synaptic plasticity in a mouse model of fragile X mental retardation.
Huber KM; Gallagher SM; Warren ST; Bear MF
Proc Natl Acad Sci U S A; 2002 May; 99(11):7746-50. PubMed ID: 12032354
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of melatonin against oxidative stress in Fmr1 knockout mice: a therapeutic research model for the fragile X syndrome.
Romero-Zerbo Y; Decara J; el Bekay R; Sanchez-Salido L; Del Arco-Herrera I; de Fonseca FR; de Diego-Otero Y
J Pineal Res; 2009 Mar; 46(2):224-34. PubMed ID: 19141086
[TBL] [Abstract][Full Text] [Related]
9. Synaptic vesicle dynamic changes in a model of fragile X.
Broek JAC; Lin Z; de Gruiter HM; van 't Spijker H; Haasdijk ED; Cox D; Ozcan S; van Cappellen GWA; Houtsmuller AB; Willemsen R; de Zeeuw CI; Bahn S
Mol Autism; 2016; 7():17. PubMed ID: 26933487
[TBL] [Abstract][Full Text] [Related]
10. Transgenic mouse model for the fragile X syndrome.
Kooy RF; D'Hooge R; Reyniers E; Bakker CE; Nagels G; De Boulle K; Storm K; Clincke G; De Deyn PP; Oostra BA; Willems PJ
Am J Med Genet; 1996 Aug; 64(2):241-5. PubMed ID: 8844056
[TBL] [Abstract][Full Text] [Related]
11. Non-parametric analysis of neurochemical effects and Arc expression in amphetamine-induced 50-kHz ultrasonic vocalization.
Hamed A; Daszczuk P; Kursa MB; Turzyńska D; Sobolewska A; Lehner M; Boguszewski PM; Szyndler J
Behav Brain Res; 2016 Oct; 312():174-85. PubMed ID: 27288591
[TBL] [Abstract][Full Text] [Related]
12. Analysis of FMR1 deletion in a subpopulation of post-mitotic neurons in mouse cortex and hippocampus.
Amiri A; Sanchez-Ortiz E; Cho W; Birnbaum SG; Xu J; McKay RM; Parada LF
Autism Res; 2014 Feb; 7(1):60-71. PubMed ID: 24408886
[TBL] [Abstract][Full Text] [Related]
13. Fragile X syndrome, the Fragile X related proteins, and animal models.
Hoogeveen AT; Willemsen R; Oostra BA
Microsc Res Tech; 2002 May; 57(3):148-55. PubMed ID: 12112450
[TBL] [Abstract][Full Text] [Related]
14. Absence of the Fragile X Mental Retardation Protein results in defects of RNA editing of neuronal mRNAs in mouse.
Filippini A; Bonini D; Lacoux C; Pacini L; Zingariello M; Sancillo L; Bosisio D; Salvi V; Mingardi J; La Via L; Zalfa F; Bagni C; Barbon A
RNA Biol; 2017 Nov; 14(11):1580-1591. PubMed ID: 28640668
[TBL] [Abstract][Full Text] [Related]
15. Long-term potentiation in the hippocampus of fragile X knockout mice.
Godfraind JM; Reyniers E; De Boulle K; D'Hooge R; De Deyn PP; Bakker CE; Oostra BA; Kooy RF; Willems PJ
Am J Med Genet; 1996 Aug; 64(2):246-51. PubMed ID: 8844057
[TBL] [Abstract][Full Text] [Related]
16. Spatiotemporal expression of PSD-95 in Fmr1 knockout mice brain.
Zhu ZW; Xu Q; Zhao ZY; Gu WZ; Wu DW
Neuropathology; 2011 Jun; 31(3):223-9. PubMed ID: 21092061
[TBL] [Abstract][Full Text] [Related]
17. Object recognition impairment in Fmr1 knockout mice is reversed by amphetamine: involvement of dopamine in the medial prefrontal cortex.
Ventura R; Pascucci T; Catania MV; Musumeci SA; Puglisi-Allegra S
Behav Pharmacol; 2004 Sep; 15(5-6):433-42. PubMed ID: 15343070
[TBL] [Abstract][Full Text] [Related]
18. [Fragile X syndrome: a model of gene-brain-behaviour relationships].
Hagerman RJ; Hagerman PJ
Rev Neurol; 2001 Oct; 33 Suppl 1():S51-7. PubMed ID: 12447820
[TBL] [Abstract][Full Text] [Related]
19. Rescue of NMDAR-dependent synaptic plasticity in Fmr1 knock-out mice.
Bostrom CA; Majaess NM; Morch K; White E; Eadie BD; Christie BR
Cereb Cortex; 2015 Jan; 25(1):271-9. PubMed ID: 23968838
[TBL] [Abstract][Full Text] [Related]
20. Aberrant differentiation of glutamatergic cells in neocortex of mouse model for fragile X syndrome.
Tervonen TA; Louhivuori V; Sun X; Hokkanen ME; Kratochwil CF; Zebryk P; Castrén E; Castrén ML
Neurobiol Dis; 2009 Feb; 33(2):250-9. PubMed ID: 19056494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
